Correlation Between CEOTRONICS and Clearside Biomedical

Can any of the company-specific risk be diversified away by investing in both CEOTRONICS and Clearside Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CEOTRONICS and Clearside Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CEOTRONICS and Clearside Biomedical, you can compare the effects of market volatilities on CEOTRONICS and Clearside Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CEOTRONICS with a short position of Clearside Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of CEOTRONICS and Clearside Biomedical.

Diversification Opportunities for CEOTRONICS and Clearside Biomedical

0.38

Correlation Coefficient

CEOTRONICS  Clearside Biomedical

Weak diversification

The 3 months correlation between CEOTRONICS and Clearside is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding CEOTRONICS and Clearside Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearside Biomedical and CEOTRONICS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CEOTRONICS are associated (or correlated) with Clearside Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearside Biomedical has no effect on the direction of CEOTRONICS i.e., CEOTRONICS and Clearside Biomedical go up and down completely randomly.

Pair Corralation between CEOTRONICS and Clearside Biomedical

Assuming the 90 days trading horizon CEOTRONICS is expected to generate 0.59 times more return on investment than Clearside Biomedical. However, CEOTRONICS is 1.68 times less risky than Clearside Biomedical. It trades about -0.01 of its potential returns per unit of risk. Clearside Biomedical is currently generating about -0.18 per unit of risk. If you would invest  1,445  in CEOTRONICS on April 25, 2025 and sell it today you would lose (90.00) from holding CEOTRONICS or give up 6.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

CEOTRONICS  vs.  Clearside Biomedical

CEOTRONICS

Risk-Adjusted Performance

Very Weak

Over the last 90 days CEOTRONICS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, CEOTRONICS is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Clearside Biomedical

Risk-Adjusted Performance

Very Weak

Over the last 90 days Clearside Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in August 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with CEOTRONICS and Clearside Biomedical

The main advantage of trading using opposite CEOTRONICS and Clearside Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CEOTRONICS position performs unexpectedly, Clearside Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearside Biomedical will offset losses from the drop in Clearside Biomedical's long position.

The idea behind CEOTRONICS and Clearside Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.